meglumine has been researched along with ENT Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
D'iachenko, TV; Kasparevich, AIu; Krivosheeva, MD; Peresadin, NA | 1 |
1 trial(s) available for meglumine and ENT Diseases
Article | Year |
---|---|
[Capabilities of pharmacological correction with Reamberin the cerebrovascular disorders with ENT diseases of the elderly patients].
Topics: Aged; Chronic Disease; Drug Monitoring; Endotoxemia; Female; Homeostasis; Humans; Hypertension; Hypoxia-Ischemia, Brain; Immunologic Factors; Infusions, Intravenous; Male; Meglumine; Neuroprotective Agents; Otorhinolaryngologic Diseases; Patient Acuity; Succinates; Treatment Outcome | 2014 |